Emeryville drug developer Adamas files for $69 million IPO
March 06, 2014 at 12:27 PM EST
Brain drug developer Adamas Pharmaceuticals Inc. hopes to raise $69 million as the fifth Bay Area life sciences company this year to file for an initial public offering...